[1. World Health Organization, Regional Office for South-East Asia. Guidelines for the diagnosis, treatment and prevention of leprosy. New Delhi: World Health Organization, Regional Office for South-East Asia; 2018.]Search in Google Scholar
[2. Worobec SM. Current approaches and future directions in the treatment of leprosy. Res Rep Trop Med. 2012;3:79-91.10.2147/RRTM.S27395606778130100775]Search in Google Scholar
[3. Setia MS, Shinde SS, Jerajani HR, Boivin JF. Is there a role for rifampicin, ofloxacin and minocycline (ROM) therapy in the treatment of leprosy? Systematic review and meta-analysis. Trop Med Int Health. 2011;16(12):1541-51.10.1111/j.1365-3156.2011.02873.x21914093]Search in Google Scholar
[4. Gautam VP. Treatment of leprosy in India. J Postgrad Med. 2009;55(3):220-4.10.4103/0022-3859.5741019884754]Search in Google Scholar
[5. Lockwood DN, Cunha Mda G. Developing new MDT regimens for MB patients; time to test ROM 12 month regimens globally. Lepr Rev. 2012;83(3):241-4.10.47276/lr.83.3.241]Search in Google Scholar
[6. Villahermosa LG, Fajardo TT Jr, Abalos RM, Cellona RV, Balagon MV, Dela Cruz EC, et al. Parallel assessment of 24 monthly doses of rifampin, ofloxacin, and minocycline versus two years of World Health Organization multi-drug therapy for multi-bacillary leprosy. Am J Trop Med Hyg. 2004;70(2):197-200.10.4269/ajtmh.2004.70.197]Search in Google Scholar
[7. Ji B, Sow S, Perani E, Lienhardt C, Diderot V, Grosset J. Bactericidal activity of a single-dose combination of ofloxacin plus minocycline, with or without rifampin, against Mycobacterium leprae in mice and in lepromatous patients. Antimicrob Agents Chemother. 1998;42(5):1115-20.10.1128/AAC.42.5.11151057559593137]Search in Google Scholar
[8. Oliveira RB, Sampaio EP, Aarestrup F, Teles RM, Silva TP, Oliveira AL, et al. Cytokines and Mycobacterium leprae induce apoptosis in human Schwann cells. J Neuropathol Exp Neurol. 2005;64(10):882-90.10.1097/01.jnen.0000182982.09978.6616215460]Search in Google Scholar
[9. Garrido-Mesa N, Zarzuelo A, Gálvez J. Minocycline: far beyond an antibiotic. Br J Pharmacol. 2013;169 (2):337-52.10.1111/bph.12139365166023441623]Search in Google Scholar
[10. Narang T, Arshdeep, Dogra S. Minocycline in leprosy patients with recent onset clinical nerve function impairment. Dermatol Ther. 2017;30(1):e12404.10.1111/dth.1240427550711]Search in Google Scholar